Alteration of glucose and glycogen in specific regions of mouse central nervous system by L-3,4-dihydroxyphenylalanine (levodopa).
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001933:Brain Stem / Q000378:metabolism; D002421:Caudate Nucleus / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D005470:Fluorometry; D005947:Glucose / Q000378:metabolism*; D006003:Glycogen / Q000378:metabolism*; D008297:Male; D008660:Metabolism / Q000187:drug effects; D051379:Mice; D013116:Spinal Cord / Q000378:metabolism; D013237:Stereoisomerism; D013997:Time Factors
D001786:Blood Glucose; D004295:Dihydroxyphenylalanine; D006003:Glycogen; D005947:Glucose